The Danish company JN MEAT INTERNATIONAL once again comes out on top being the world’s best steak producer
After being crowned best steak producer in the world 2018 and 2019, JN MEAT INTERNATIONAL once again came out on top at the World Steak Challenge 2021 (after the 2020 competition was cancelled due to Covid)
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211116005983/en/
The Danish company JN MEAT INTERNATIONAL once again comes out on top being the world’s best steak producer. (Photo: Business Wire)
Almost 400 steaks from 23 countries competed this year in Dublin November 10th 2021.
During a 12 hour session a professional jury together with a consumer-jury judged the many steaks in terms of taste, tenderness and appearance.
The juries found that a sirloin steak from the SASHI series from JN MEAT INTERNATIONAL was the overall best of all steaks.
As a result, this steak was crowned the best in the world, and the company the best steak-producer in the world for the third time in a row, after also winning in 2018 and 2019.
The awarded steak is a product in the SASHI series of quality beef which consists of beef with different characteristics and origins.
Amongst these brands are Freygaard-Nordic Nature Beef origin Finland, Prussian Black origin Germany, Cloverfield origin UK/Ireland and SABOR origin Argentina.
The founder of JN MEAT INTERNATIONAL, John SASHI Nielsen made the following comments after the announcement of the winner 10.11-2021:
So happy and proud that despite being in a lower division in terms of size and budget once again we are playing in the Champions League… of beef. I am also very pleased to learn that most of us competing at the contest share the same passion and goal, which is being able to offer beef with a high eating quality but at the same time making it sustainably. No doubt what the future holds for our industry, being that less is more. Current and future generations will still eat beef, but much less and much better beef, I am convinced. As a consequence, at JN MEAT INTERNATIONAL we shall continue to follow our motto: EAT LESS CHOOSE BETTER…
Facts
JN Meat International has 70 employees and produces a large number of its own meat cuts for both Danish and international customers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005983/en/
Contact information
Contacts:
John Sashi Nielsen, Founder and CEO
Mobil +45 4040 4082
Mail: jn@jnmeat.dk
Steffen Nagel, Head of Global Sales & Export
Mobil +45 2161 5018
Mail:
sn@jnmeat.dk
JN MEAT INTERNATIONAL
Elmedalsvej 8
DK 4200 Slagelse
Tlf.: +45 5858 0200
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ThinkPalm and RAD Join Forces to Deliver a Smart Business IoT Solution, Offering CSPs a Competitive Edge17.9.2025 10:00:00 EEST | Press release
ThinkPalm and RAD have partnered to integrate NetvirE, ThinkPalm’s advanced IIoT platform, and RAD’s Smart Business IoT solution to enable smarter industrial operations. This collaboration gives Communication Service Providers (CSPs) a competitive edge in digital transformation, remote asset management, and IoT services. 360°, End-to-End IoT Offering The Smart Business IoT solution combines advanced IoT gateways, smart sensors, and intelligent dashboards into one integrated system. It delivers real-time, historical, and AI-driven insights for remote monitoring, predictive maintenance, and activity detection, enabling CSPs to move beyond SIM-based plans and offer high-value, integrated solutions for smarter asset decisions without requiring IT expertise. Expanding CSP Horizons in the UK and Europe For CSPs in competitive markets like the UK and Europe, ThinkPalm’s expertise combined with RAD's industry leadership offers an unparalleled advantage. Together, they deliver secure, tailored
EADV 2025: Almirall Advances Skin Science and Leads Innovation for Holistic Patient Care in Medical Dermatology17.9.2025 09:57:00 EEST | Press release
Almirall, S.A. (ALM) a global biopharmaceutical company dedicated to medical dermatology, is a major contributor to the 2025 European Academy of Dermatology and Venereology Congress (EADV) presenting new data across its broad portfolio of dermatological treatments including new real-world data of lebrikizumab on atopic dermatitis, new clinical data of tildrakizumab on psoriasis and tirbanibulin on actinic keratosis. The 34th EADV congress will take place from September 17 to 20 in Paris, France. At the congress, Almirall contributes a total of 44 scientific abstracts focused on advancing patient care across the company’s broad portfolio of dermatological treatments including atopic dermatitis, psoriasis, actinic keratosis, and hidradenitis suppurativa. With a strong emphasis on real-world evidence, patient-reported outcomes, and well-being, Almirall’s scientific programme includes multiple presentations, two expert-led symposia on psoriasis and atopic dermatitis, and an interactive exh
SES delivered unprecedented MEO satellite connectivity for French Navy’s Clemenceau 25 mission17.9.2025 09:50:00 EEST | Press release
SES announced today that the French Navy’s aircraft carrier Charles de Gaulle leveraged its secure and reliable O3b mPOWER satcom service – Managed Naval mPOWERED – during the Clemenceau 25 mission. This high-throughput, low-latency Medium Earth Orbit (MEO) connectivity solution supported all of the aircraft carrier’s operations, while facilitating collaboration with mission partners. During the five-month deployment, the French Carrier Strike Group (GAN) covered 40,000 nautical miles and conducted various exercises and joint activities with around twenty allied nations. The connectivity provided by SES ensured optimal performance and uninterrupted operational availability for the aircraft carrier’s mission-critical applications. Thanks to the global reach, reliability and exceptional high-speed capacity of the Managed Naval mPOWERED solution, which can deliver several hundred Mb/s of guaranteed throughput, the Charles de Gaulle aircraft carrier enjoyed continuous connectivity througho
Deepfakes Already Hitting Businesses as Often as Traditional Fraud, Regula Survey Finds17.9.2025 09:00:00 EEST | Press release
Fresh survey data from Regula, a global developer of identity verification (IDV) solutions and forensic devices, shows that the line between traditional fraud and impersonation attacks has vanished. Identity spoofing, biometric fraud, and AI-powered deepfakes have already struck one in three organizations worldwide, catching up with long-standing fraud tactics like forged documents and social engineering. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916314726/en/ Regula’s survey shows that impersonation attacks overtake traditional fraud schemes. Three impersonation-driven tactics now dominate the fraud playbook, each exploiting weaknesses in verification: Identity spoofing (reported by 34% of organizations) — Holding up a printed photo, replaying a video, or showing a screen image to a camera. Often used to mass-open accounts for scams or mule networks. Biometric fraud (34%) — Physical deceptions like fake fingerprints
Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 202517.9.2025 08:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced new 24-week interim data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). These data will support the planned regulatory submissions for povorcitinib in HS in Europe and the United States in 2025 and early 2026, respectively. The presentation will take place today at 2:45 p.m. CEST during a late-breaking oral presentation (Session: Late Breaking News; Presentation ID D1T01.1C) at the European Association of Dermatology and Venereology (EADV) 2025 Congress. “HS remains a challenging and often debilitating condition and many patients are in need of new, well-tolerated and effective therapies that address prominent signs and symptoms of the disease, including inflammatory lesions and pain,” said Pablo J. Cagnoni, M.D., President and Head of Res
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom